Cargando…
Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery
BACKGROUND: Mesenchymal stem cell (MSC) based-treatments of cartilage injury are promising but impaired by high levels of hypertrophy after chondrogenic induction with several bone morphogenetic protein superfamily members (BMPs). As an alternative, this study investigates the chondrogenic induction...
Autores principales: | Weissenberger, M., Weissenberger, M. H., Gilbert, F., Groll, J., Evans, C. H., Steinert, A. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026978/ https://www.ncbi.nlm.nih.gov/pubmed/32066427 http://dx.doi.org/10.1186/s12891-020-3137-4 |
Ejemplares similares
-
Comparative in vitro treatment of mesenchymal stromal cells with GDF-5 and R57A induces chondrogenic differentiation while limiting chondrogenic hypertrophy
por: Weißenberger, Manuel, et al.
Publicado: (2023) -
Different types of cartilage neotissue fabricated from collagen hydrogels and mesenchymal stromal cells via SOX9, TGFB1 or BMP2 gene transfer
por: Weißenberger, Manuel, et al.
Publicado: (2020) -
Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells
por: Steinert, Andre F, et al.
Publicado: (2012) -
Delivery of the Sox9 gene promotes chondrogenic
differentiation of human umbilical cord blood-derived mesenchymal stem cells in an
in vitro model
por: Wang, Z.H., et al.
Publicado: (2014) -
Chondrogenic Differentiation of Human Mesenchymal Stem Cells via SOX9 Delivery in Cationic Niosomes
por: Carballo-Pedrares, Natalia, et al.
Publicado: (2022)